ArticlePharmaceuticals (Basel, Switzerland)2025
The Role of Outcome Response Rate in Planning Biosimilar Studies Using Different Evaluation Metrics.
Liyi Cen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this paperpooled itcites it